课题基金 / 基金详情

项目摘要

项目成果

PAULA C BICKFORD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A major theme of this project is understandli>g the causes and condittons that lead to a state of chronic up- regualtion of pro-inflammatory process in aging that are the backround within whk:h neurodegeneartive disease occurs. We have demonstrated that loss of the chemokine fractalkine (FKN) is an early event in brain aging and that this precipitates a bias towards pro-inflammatory signals such as ILI3 and TNFa. Fractalkine (CX3CL1) is expressed in neurons and the receptor (CX3CR1) is on microglia. Ligation of CX3CR1 resullts in down regulation of 11-1 p, TNFa and other pro-inflammatory cytokines. We will examine regulation of CX3CL1 as it is present as both a cleaved soluble fonn and a membrane bound fomi. There is evidence that the membrane bound form and the soluble forni control different aspects of immune regulation, however this is poorly understood. To address this questton we have generated rAAVQ vectors that express 1 )soluble, 2) native and 3) a mutant uncleaved CX3CL1. We wUI use these unique and novel tools to understand the role these forms of FKN in control of microglial function and its role to regulate neural plasticity measured as neurogensis and long term potentiaion (LTP) and cf^ntiive function in aged mice and CX3CL1 deficient mice to dtermine if replacement of FKN at an early age (12 months) will lead to king lasting regulation of microglial function and prevent increased innate immune function with age and preverit a loss in neural plasticity and cognitive function. In aim 2 we will examine if neurr^l specify versus astrocyte specific expression of CX3CL1 alters the functional properties. CX3CL1 is normally epxressed in nuerons, hoever under certain condittons it has t)een observed in astrocytes. In aim 3 we will then look further at the role of CX3CL1 and its receptor as it may interact with Ml and M2 responses to stimuli with age, as we have obsen^ed blunted responses to iL4/IL13 in the aged brain. We will examine this in tfie CX3CR1 null and CX3CL1 null mice as well as nonnai aged C57BL/6 mice. We will isolate primary microglia for ex vivo cell culture experiments to detemnine if any changes in regulation of l\^1 and M2 responses are cell autonomous or non cell autononwus. RELEVANCE (See instnjctions): Aging is a primary risk factor for many neurodegenerative diseases and also can be associated with cognitive slowir^. Understanding key molecules in the brain that underly changes in brain aging that make the brain more suceptible to disease is critical and can lead to new approacfies to reduce the incidence or severity of neurodegenerative diseases and declines in cognitive function with age
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aging and Innate immune system resilience in TBI
  • 批准号:
    10616497
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    PAULA C BICKFORD
  • 依托单位:
Aging and Innate immune system resilience in TBI
  • 批准号:
    10369760
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    PAULA C BICKFORD
  • 依托单位:
ShEEP Request for QuantStudio 12K Flex Real-Time PCR system
  • 批准号:
    9796289
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    PAULA C BICKFORD
  • 依托单位:
BLRD Research Career Scientist Award Application
  • 批准号:
    10618267
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2018
  • 负责人:
    PAULA C BICKFORD
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: